本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨

新浪基金05-28

5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。　　100%创新药研发标的——港股通创新药ETF华宝（520880）午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝（520880...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2638196657?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-28 14:09","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2638196657","market":"us","top_or_hot":-1,"title":"本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨","media":"新浪基金","content":"<div>\n<p>5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。\n　　100%创新药研发标的——港股通创新药ETF华宝（520880）午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。\n\n　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝（520880...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-28 14:09 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml><strong>新浪基金</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。\n　　100%创新药研发标的——港股通创新药ETF华宝（520880）午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。\n\n　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝（520880...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0417516571.SGD","symbol_name":"Allianz Oriental Income Cl AT Acc SGD","start_time":0,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml","article_id":"2638196657","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638196657","pubTimestamp":1779948540,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。　　100%创新药研发标的——港股通创新药ETF华宝午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝标的指数区间跌幅已超过30%，当前位置或接近本轮调整底部区间，配置性价比凸显。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","520880":"港股通创新药ETF华宝","688235":"百济神州","LU0417516571.SGD":"Allianz Oriental Income Cl AT Acc SGD","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","LU2399975544.HKD":"ALLIANZ ALL CHINA EQUITY \"AT\" (HKD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK4588":"碎股","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","BK1500":"做空集合股","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","09926":"康方生物","ONC":"百济神州","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","06978":"永泰生物-B","BK1588":"回港中概股","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU1720050803.USD":"安联全方位中国股票基金","BK1161":"生物科技","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU0348783233.USD":"安联东方收入型 CI A Dis美元","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","VXUS":"国际股票ETF-Vanguard","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU1961090484.USD":"ALLIANZ ALL CHINA EQUITY \"A\" (USD) INC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","BK4526":"热门中概股","LU0348784397.USD":"ALLIANZ ORIENTAL INCOME \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","BK1574":"生物医药B类股","BK4139":"生物科技","06160":"百济神州","LU0561508036.HKD":"ALLIANZ CHINA EQUITY \"A\" (HKD) INC","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","BK0239":"医药制造","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","BK1583":"高瓴概念","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC"},"translate_title":"This round of adjustment is over 8 months! Hong Kong Stock Connect innovative drugs continue to bottom out, and 520880 hits a new low! Kangfang Bio, BeiGene and other weighted leaders are depleted","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1.5,"520880":1.5,"688235":1.5,"ONC":1.5,"06978":1.5,"09926":1.5,"06160":1.5,"VXUS":1.5},"content_text":"5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。\n　　100%创新药研发标的——港股通创新药ETF华宝（520880）午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。\n\n　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝（520880）标的指数区间跌幅已超过30%，当前位置或接近本轮调整底部区间，配置性价比凸显。\n\n　　注：恒生港股通创新药精选指数2021-2025年年度历史收益分别为：-22.72%、-16.48%、-19.76%、-14.16%、66.32%。回测历史业绩不预示指数未来表现。\n　　回归投资底层逻辑，创新药基本面扎实：2026年Q1 BD出海超600亿美元，恒瑞152亿美元平台型大交易标志行业升维；政策端首发定价机制优化、医保商保双目录衔接形成持续支撑；港股通创新药已整体进入盈利阶段。\n　　事件层面，2026年美国临床肿瘤学会（ASCO）年会将于明日在芝加哥举行。据悉，中国学者主导并入选口头报告、快速口头报告、临床科学研讨会及继续教育专场等重要环节的研究摘要达95项，较2024年48项、2025年72项再创新高。\n　　低位吸纳创新药核心资产，认准两大投资利器：\n　　投纯正创新药，认准港股通创新药ETF华宝（520880），100%布局创新药研发类公司，前十大权重股占比超七成，龙头属性突出，底层资产是港股，高弹性、T+0。\n　　希望降低波动，选场内唯一药ETF华宝（562050），“70%创新药+30%中药”独家配比，全市场稀缺标的，兼具创新药高成长及中药高股息。\n\n　　注“场内唯一药ETF华宝（562050）”：根据沪深交易所数据，截至当前，药ETF华宝是全市场唯一一只跟踪中证制药指数的ETF。\n　　注：ETF基金不收取销售服务费。投资者在申购或赎回基金份额时，申购赎回代理券商可按照不超过0.5%的标准收取佣金，其中包含证券交易所、登记机构等收取的相关费用。基金费率详见各基金法律文件。\n　　风险提示：文中指数成份股仅作展示，个股描述不作为任何形式的投资建议，也不代表管理人旗下任何基金的持仓信息和交易动向。基金管理人评估的药ETF华宝及其联接基金的风险等级为R3-中风险，适宜平衡型（C3）及以上的投资者，港股通创新药ETF华宝及其联接基金的风险等级为R4-中高风险，适宜积极型（C4）及以上的投资者。任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，投资人须对任何自主决定的投资行为负责。另，本文中的任何观点、分析及预测不构成对阅读者任何形式的投资建议，亦不对因使用本文内容所引发的直接或间接损失负任何责任。基金管理人管理的其他基金的业绩并不构成基金业绩表现的保证，基金的过往业绩并不代表其未来表现，基金投资有风险。\n\nMACD金叉信号形成，这些股涨势不错！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：常福强","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638196657","isCrawlerRequest":true}